Events

ACTRIS signs MOU with National University Cancer Institute, Singapore (NCIS)

ACTRIS and the National University Cancer Institute, Singapore (NCIS) signed an MOU to strengthen collaboration in cell therapy development and GMP manufacturing, supporting the translation of innovative therapies to patients.

From Insights to Impact: ACTRIS at ISCT Asia 2026

At ISCT Asia 2026, ACTRIS brought together researchers, clinicians and industry professionals through hands-on training, expert-led sessions and educational programmes focused on advancing cell and gene therapies.

Kazakhstani Delegation visits ACTRIS to learn about Singapore's Clinical Research and Cell & Gene Therapy Ecosystem

Advancing Innovation, Inclusion and Impact: ACTRIS at SCRI Clinical Trials Symposium 2026

ACTRIS participated in the SCRI Clinical Trials Symposium 2026, joining discussions on the future of clinical trials and engaging the wider clinical research community.

Post CRIS Connect - Navigating Cell, Tissue and Gene Therapy Product (CTGTP) Development in ACTRIS

Close to 190 participants joined the CRIS Connect Webinar to gain insights into the regulatory, project management and manufacturing considerations that support successful CTGTP development in Singapore.

Study Trip to Cell Therapies Pty Ltd

ACTRIS visited Cell Therapies Pty Ltd (CTPL) for a three-day training programme, fostering knowledge exchange and collaboration.

Humans of CRIS | Father's Day

CRIS Hosts KKH Leadership Visit

Post CRIS Connect - Advancing CTGTPs in Singapore: Clinical Translation and Clinical Care

Discover how Singapore is advancing CTGTPs through ecosystem building, clinical expertise, and manufacturing capabilities, while exploring the future of CAR-T and next-generation cell therapies.

CRIS Work Plan Seminar 2026